QQQ   444.84 (+0.00%)
AAPL   170.60 (-1.56%)
MSFT   420.85 (-0.14%)
META   489.48 (-0.89%)
GOOGL   150.67 (-0.13%)
AMZN   180.80 (+0.54%)
TSLA   176.81 (-1.68%)
NVDA   909.13 (+0.73%)
NIO   4.61 (-1.28%)
AMD   181.84 (+1.25%)
BABA   72.50 (+1.27%)
T   17.56 (+0.06%)
F   13.24 (+1.38%)
MU   118.37 (-0.65%)
CGC   9.52 (-0.31%)
GE   175.14 (-2.76%)
DIS   122.68 (+1.41%)
AMC   3.74 (-13.82%)
PFE   27.90 (+0.43%)
PYPL   66.85 (+0.42%)
XOM   115.43 (+0.40%)
QQQ   444.84 (+0.00%)
AAPL   170.60 (-1.56%)
MSFT   420.85 (-0.14%)
META   489.48 (-0.89%)
GOOGL   150.67 (-0.13%)
AMZN   180.80 (+0.54%)
TSLA   176.81 (-1.68%)
NVDA   909.13 (+0.73%)
NIO   4.61 (-1.28%)
AMD   181.84 (+1.25%)
BABA   72.50 (+1.27%)
T   17.56 (+0.06%)
F   13.24 (+1.38%)
MU   118.37 (-0.65%)
CGC   9.52 (-0.31%)
GE   175.14 (-2.76%)
DIS   122.68 (+1.41%)
AMC   3.74 (-13.82%)
PFE   27.90 (+0.43%)
PYPL   66.85 (+0.42%)
XOM   115.43 (+0.40%)
QQQ   444.84 (+0.00%)
AAPL   170.60 (-1.56%)
MSFT   420.85 (-0.14%)
META   489.48 (-0.89%)
GOOGL   150.67 (-0.13%)
AMZN   180.80 (+0.54%)
TSLA   176.81 (-1.68%)
NVDA   909.13 (+0.73%)
NIO   4.61 (-1.28%)
AMD   181.84 (+1.25%)
BABA   72.50 (+1.27%)
T   17.56 (+0.06%)
F   13.24 (+1.38%)
MU   118.37 (-0.65%)
CGC   9.52 (-0.31%)
GE   175.14 (-2.76%)
DIS   122.68 (+1.41%)
AMC   3.74 (-13.82%)
PFE   27.90 (+0.43%)
PYPL   66.85 (+0.42%)
XOM   115.43 (+0.40%)
QQQ   444.84 (+0.00%)
AAPL   170.60 (-1.56%)
MSFT   420.85 (-0.14%)
META   489.48 (-0.89%)
GOOGL   150.67 (-0.13%)
AMZN   180.80 (+0.54%)
TSLA   176.81 (-1.68%)
NVDA   909.13 (+0.73%)
NIO   4.61 (-1.28%)
AMD   181.84 (+1.25%)
BABA   72.50 (+1.27%)
T   17.56 (+0.06%)
F   13.24 (+1.38%)
MU   118.37 (-0.65%)
CGC   9.52 (-0.31%)
GE   175.14 (-2.76%)
DIS   122.68 (+1.41%)
AMC   3.74 (-13.82%)
PFE   27.90 (+0.43%)
PYPL   66.85 (+0.42%)
XOM   115.43 (+0.40%)
NASDAQ:MDXH

MDxHealth (MDXH) Stock Price, News & Analysis

$2.77
+0.31 (+12.60%)
(As of 11:27 AM ET)
Today's Range
$2.48
$2.78
50-Day Range
$2.46
$4.18
52-Week Range
$2.15
$4.64
Volume
200,176 shs
Average Volume
75,583 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$28.33

MDxHealth MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,037.9% Upside
$28.33 Price Target
Short Interest
Healthy
0.16% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.02) to ($0.75) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.50 out of 5 stars

MDXH stock logo

About MDxHealth Stock (NASDAQ:MDXH)

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

MDXH Stock Price History

MDXH Stock News Headlines

Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Mdxhealth Announces Resignation of Board Member
Mdxhealth Share Price (MDXH.BR)
mdxhealth: MDxHealth Reports Preliminary Q3-2023 Revenues
BTIG Sticks to Its Buy Rating for MDxHealth S.A. Sponsored ADR (MDXH)
MDxHealth Reports Q2 and Half Year 2023 Results
See More Headlines
Receive MDXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/06/2024
Today
3/28/2024
Next Earnings (Estimated)
6/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
NASDAQ:MDXH
Employees
252
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$28.33
High Stock Price Target
$70.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+949.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$70.19 million
Book Value
$5.97 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Michael K. McGarrity (Age 61)
    CEO & Executive Director
    Comp: $579.32k
  • Mr. Ron Kalfus (Age 50)
    Chief Financial Officer
  • Mr. Joseph Sollee (Age 59)
    Executive VP of Corporate Development & General Counsel
  • Mr. John A. Bellano (Age 55)
    Chief Commercial Officer
  • Ms. Miriam Reyes (Age 51)
    Executive Vice President of Operations
  • Dr. Jason Poole Ph.D.
    Chief Scientific Officer

MDXH Stock Analysis - Frequently Asked Questions

Should I buy or sell MDxHealth stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MDxHealth in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MDXH shares.
View MDXH analyst ratings
or view top-rated stocks.

What is MDxHealth's stock price target for 2024?

4 Wall Street analysts have issued 1-year price targets for MDxHealth's stock. Their MDXH share price targets range from $7.00 to $70.00. On average, they predict the company's stock price to reach $28.33 in the next twelve months. This suggests a possible upside of 1,037.9% from the stock's current price.
View analysts price targets for MDXH
or view top-rated stocks among Wall Street analysts.

How have MDXH shares performed in 2024?

MDxHealth's stock was trading at $3.94 at the beginning of the year. Since then, MDXH shares have decreased by 36.8% and is now trading at $2.49.
View the best growth stocks for 2024 here
.

When is MDxHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 5th 2024.
View our MDXH earnings forecast
.

How were MDxHealth's earnings last quarter?

MDxHealth SA (NASDAQ:MDXH) released its quarterly earnings results on Wednesday, March, 6th. The company reported ($0.39) earnings per share (EPS) for the quarter. The firm had revenue of $19.40 million for the quarter.

When did MDxHealth's stock split?

Shares of MDxHealth reverse split on Friday, December 29th 2023. The 1-10 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What guidance has MDxHealth issued on next quarter's earnings?

MDxHealth issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $79.0 million-$81.0 million, compared to the consensus revenue estimate of $79.6 million.

When did MDxHealth IPO?

MDxHealth (MDXH) raised $45 million in an IPO on Thursday, November 4th 2021. The company issued 3,750,000 shares at a price of $12.00 per share.

Who are MDxHealth's major shareholders?

MDxHealth's stock is owned by a variety of institutional and retail investors. Top institutional investors include MVM Partners LLC (16.67%) and Perkins Capital Management Inc. (1.52%).
View institutional ownership trends
.

How do I buy shares of MDxHealth?

Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MDXH) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners